78.35 USD
-0.93 (-1.17%)
At close: Feb 10, 2026
78.35 USD
0 (0%)
After Hours: 2/10/2026, 4:30:02 PM
HQY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. HQY has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. HQY is growing strongly while it is still valued neutral. This is a good combination! With these ratings, HQY could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
- HQY had positive earnings in the past year.
- In the past year HQY had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: HQY reported negative net income in multiple years.
- In the past 5 years HQY always reported a positive cash flow from operatings.
1.2 Ratios
- HQY has a better Return On Assets (5.65%) than 80.39% of its industry peers.
- Looking at the Return On Equity, with a value of 8.99%, HQY is in the better half of the industry, outperforming 68.63% of the companies in the same industry.
- The Return On Invested Capital of HQY (7.20%) is better than 68.63% of its industry peers.
- HQY had an Average Return On Invested Capital over the past 3 years of 3.06%. This is significantly below the industry average of 9.11%.
- The 3 year average ROIC (3.06%) for HQY is below the current ROIC(7.20%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.65% | ||
| ROE | 8.99% | ||
| ROIC | 7.2% |
ROA(3y)1.24%
ROA(5y)0.52%
ROE(3y)1.98%
ROE(5y)0.84%
ROIC(3y)3.06%
ROIC(5y)2.55%
1.3 Margins
- HQY has a Profit Margin of 14.86%. This is amongst the best in the industry. HQY outperforms 98.04% of its industry peers.
- HQY's Profit Margin has improved in the last couple of years.
- The Operating Margin of HQY (23.20%) is better than 98.04% of its industry peers.
- HQY's Operating Margin has declined in the last couple of years.
- The Gross Margin of HQY (67.72%) is better than 86.27% of its industry peers.
- In the last couple of years the Gross Margin of HQY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.2% | ||
| PM (TTM) | 14.86% | ||
| GM | 67.72% |
OM growth 3Y46.64%
OM growth 5Y-3.79%
PM growth 3YN/A
PM growth 5Y1.57%
GM growth 3Y4.97%
GM growth 5Y1.12%
2. Health
2.1 Basic Checks
- HQY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- HQY has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, HQY has more shares outstanding
- The debt/assets ratio for HQY is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 4.11 indicates that HQY is not in any danger for bankruptcy at the moment.
- HQY has a Altman-Z score of 4.11. This is in the better half of the industry: HQY outperforms 75.49% of its industry peers.
- The Debt to FCF ratio of HQY is 2.71, which is a good value as it means it would take HQY, 2.71 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of HQY (2.71) is better than 75.49% of its industry peers.
- A Debt/Equity ratio of 0.46 indicates that HQY is not too dependend on debt financing.
- With a decent Debt to Equity ratio value of 0.46, HQY is doing good in the industry, outperforming 62.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 2.71 | ||
| Altman-Z | 4.11 |
ROIC/WACC0.82
WACC8.79%
2.3 Liquidity
- HQY has a Current Ratio of 4.13. This indicates that HQY is financially healthy and has no problem in meeting its short term obligations.
- With an excellent Current ratio value of 4.13, HQY belongs to the best of the industry, outperforming 90.20% of the companies in the same industry.
- A Quick Ratio of 4.13 indicates that HQY has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 4.13, HQY belongs to the top of the industry, outperforming 91.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.13 | ||
| Quick Ratio | 4.13 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 22.15% over the past year.
- Measured over the past years, HQY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.72% on average per year.
- The Revenue has grown by 12.20% in the past year. This is quite good.
- Measured over the past years, HQY shows a quite strong growth in Revenue. The Revenue has been growing by 17.66% on average per year.
EPS 1Y (TTM)22.15%
EPS 3Y33.01%
EPS 5Y12.72%
EPS Q2Q%29.49%
Revenue 1Y (TTM)12.2%
Revenue growth 3Y16.61%
Revenue growth 5Y17.66%
Sales Q2Q%7.23%
3.2 Future
- The Earnings Per Share is expected to grow by 19.43% on average over the next years. This is quite good.
- HQY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.51% yearly.
EPS Next Y27.51%
EPS Next 2Y21.45%
EPS Next 3Y19.43%
EPS Next 5YN/A
Revenue Next Year9.78%
Revenue Next 2Y8.66%
Revenue Next 3Y8.51%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 20.89 indicates a rather expensive valuation of HQY.
- Compared to the rest of the industry, the Price/Earnings ratio of HQY indicates a somewhat cheap valuation: HQY is cheaper than 68.63% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 28.06, HQY is valued a bit cheaper.
- Based on the Price/Forward Earnings ratio of 16.97, the valuation of HQY can be described as correct.
- HQY's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HQY is cheaper than 72.55% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of HQY to the average of the S&P500 Index (27.86), we can say HQY is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.89 | ||
| Fwd PE | 16.97 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as HQY.
- Based on the Price/Free Cash Flow ratio, HQY is valued a bit cheaper than 69.61% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.46 | ||
| EV/EBITDA | 16.38 |
4.3 Compensation for Growth
- HQY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of HQY may justify a higher PE ratio.
- HQY's earnings are expected to grow with 19.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.76
PEG (5Y)1.64
EPS Next 2Y21.45%
EPS Next 3Y19.43%
5. Dividend
5.1 Amount
- No dividends for HQY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
78.35
-0.93 (-1.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)12-03 2025-12-03/amc
Earnings (Next)03-16 2026-03-16/amc
Inst Owners107.91%
Inst Owner Change-0.82%
Ins Owners1.58%
Ins Owner Change-0.09%
Market Cap6.69B
Revenue(TTM)1.29B
Net Income(TTM)191.83M
Analysts84
Price Target121.51 (55.09%)
Short Float %4.37%
Short Ratio3.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.96%
Min EPS beat(2)7.72%
Max EPS beat(2)16.19%
EPS beat(4)3
Avg EPS beat(4)9.14%
Min EPS beat(4)-5.01%
Max EPS beat(4)17.64%
EPS beat(8)7
Avg EPS beat(8)12.04%
EPS beat(12)11
Avg EPS beat(12)12.62%
EPS beat(16)13
Avg EPS beat(16)9.57%
Revenue beat(2)1
Avg Revenue beat(2)-0.04%
Min Revenue beat(2)-0.64%
Max Revenue beat(2)0.56%
Revenue beat(4)3
Avg Revenue beat(4)0.59%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)1.57%
Revenue beat(8)7
Avg Revenue beat(8)1.48%
Revenue beat(12)11
Avg Revenue beat(12)1.25%
Revenue beat(16)14
Avg Revenue beat(16)1.19%
PT rev (1m)-1.85%
PT rev (3m)-1.92%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)-3.36%
EPS NY rev (1m)0%
EPS NY rev (3m)2.25%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.89 | ||
| Fwd PE | 16.97 | ||
| P/S | 5.19 | ||
| P/FCF | 18.46 | ||
| P/OCF | 16.13 | ||
| P/B | 3.14 | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.38 |
EPS(TTM)3.75
EY4.79%
EPS(NY)4.62
Fwd EY5.89%
FCF(TTM)4.24
FCFY5.42%
OCF(TTM)4.86
OCFY6.2%
SpS15.11
BVpS24.98
TBVpS-7.48
PEG (NY)0.76
PEG (5Y)1.64
Graham Number45.91
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.65% | ||
| ROE | 8.99% | ||
| ROCE | 9.14% | ||
| ROIC | 7.2% | ||
| ROICexc | 7.95% | ||
| ROICexgc | 120.82% | ||
| OM | 23.2% | ||
| PM (TTM) | 14.86% | ||
| GM | 67.72% | ||
| FCFM | 28.1% |
ROA(3y)1.24%
ROA(5y)0.52%
ROE(3y)1.98%
ROE(5y)0.84%
ROIC(3y)3.06%
ROIC(5y)2.55%
ROICexc(3y)3.42%
ROICexc(5y)2.86%
ROICexgc(3y)66.66%
ROICexgc(5y)61.07%
ROCE(3y)3.88%
ROCE(5y)3.24%
ROICexgc growth 3Y56.29%
ROICexgc growth 5Y6.43%
ROICexc growth 3Y65.75%
ROICexc growth 5Y6.63%
OM growth 3Y46.64%
OM growth 5Y-3.79%
PM growth 3YN/A
PM growth 5Y1.57%
GM growth 3Y4.97%
GM growth 5Y1.12%
F-Score9
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 2.71 | ||
| Debt/EBITDA | 2.16 | ||
| Cap/Depr | 33.68% | ||
| Cap/Sales | 4.05% | ||
| Interest Coverage | 5.46 | ||
| Cash Conversion | 91.28% | ||
| Profit Quality | 189.06% | ||
| Current Ratio | 4.13 | ||
| Quick Ratio | 4.13 | ||
| Altman-Z | 4.11 |
F-Score9
WACC8.79%
ROIC/WACC0.82
Cap/Depr(3y)138.38%
Cap/Depr(5y)119.74%
Cap/Sales(3y)20.19%
Cap/Sales(5y)18.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.15%
EPS 3Y33.01%
EPS 5Y12.72%
EPS Q2Q%29.49%
EPS Next Y27.51%
EPS Next 2Y21.45%
EPS Next 3Y19.43%
EPS Next 5YN/A
Revenue 1Y (TTM)12.2%
Revenue growth 3Y16.61%
Revenue growth 5Y17.66%
Sales Q2Q%7.23%
Revenue Next Year9.78%
Revenue Next 2Y8.66%
Revenue Next 3Y8.51%
Revenue Next 5YN/A
EBIT growth 1Y49.93%
EBIT growth 3Y71.01%
EBIT growth 5Y13.2%
EBIT Next Year235.12%
EBIT Next 3Y61.46%
EBIT Next 5YN/A
FCF growth 1Y105.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.54%
OCF growth 3Y34.08%
OCF growth 5Y26.48%
HEALTHEQUITY INC / HQY FAQ
What is the ChartMill fundamental rating of HEALTHEQUITY INC (HQY) stock?
ChartMill assigns a fundamental rating of 6 / 10 to HQY.
What is the valuation status of HEALTHEQUITY INC (HQY) stock?
ChartMill assigns a valuation rating of 5 / 10 to HEALTHEQUITY INC (HQY). This can be considered as Fairly Valued.
How profitable is HEALTHEQUITY INC (HQY) stock?
HEALTHEQUITY INC (HQY) has a profitability rating of 7 / 10.
What are the PE and PB ratios of HEALTHEQUITY INC (HQY) stock?
The Price/Earnings (PE) ratio for HEALTHEQUITY INC (HQY) is 20.89 and the Price/Book (PB) ratio is 3.14.
How financially healthy is HEALTHEQUITY INC?
The financial health rating of HEALTHEQUITY INC (HQY) is 7 / 10.